Cellectar Biosciences Inc
NASDAQ:CLRB

Watchlist Manager
Cellectar Biosciences Inc Logo
Cellectar Biosciences Inc
NASDAQ:CLRB
Watchlist
Price: 0.2491 USD -1.15% Market Closed
Market Cap: 11.5m USD

Intrinsic Value

CLRB doesn't have a meaningful market cap.
CLRB's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CLRB stock under the Base Case scenario is 0.3018 USD. Compared to the current market price of 0.2491 USD, Cellectar Biosciences Inc is Undervalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLRB Intrinsic Value
0.3018 USD
Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cellectar Biosciences Inc

Valuation History Unavailable

Historical valuation for CLRB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cellectar Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cellectar Biosciences Inc

Current Assets 14.9m
Cash & Short-Term Investments 13.9m
Other Current Assets 987.5k
Non-Current Assets 1.1m
PP&E 1.1m
Other Non-Current Assets 29.8k
Efficiency

Free Cash Flow Analysis
Cellectar Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cellectar Biosciences Inc

Revenue
0 USD
Operating Expenses
-46.2m USD
Operating Income
-46.2m USD
Other Expenses
21.6m USD
Net Income
-24.5m USD
Fundamental Scores

CLRB Profitability Score
Profitability Due Diligence

Cellectar Biosciences Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
ROIC is Increasing
Negative Free Cash Flow
47/100
Profitability
Score

Cellectar Biosciences Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

CLRB Solvency Score
Solvency Due Diligence

Cellectar Biosciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Cellectar Biosciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLRB Price Targets Summary
Cellectar Biosciences Inc

There are no price targets for CLRB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cellectar Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CLRB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CLRB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CLRB stock?

The intrinsic value of one CLRB stock under the Base Case scenario is 0.3018 USD.

Is CLRB stock undervalued or overvalued?

Compared to the current market price of 0.2491 USD, Cellectar Biosciences Inc is Undervalued by 17%.

Back to Top